Panakeia
Entrepreneur First '19London, GB · Founded 2019 · 3 known investors
Panakeia develops AI technology that derives multi-omics and biomarker information directly from routine H&E-stained tissue images, producing molecular profiling results in minutes rather than days or weeks. The company targets clinical diagnostics and drug development applications.
AI & Machine LearningBiotechHealthtech
Founders & leadership
Panakeia was founded in 2019 by Pahini Pandya and Pandu Raharja.
PP
Pahini PandyainCEOPahini completed a PhD in cell and molecular biophysics at King's College London, where she studied why protease inhibitors have failed as cancer therapeutics, and subsequently worked as a research associate at the University of Cambridge. She is also a member of the World Economic Forum's Global Shapers Community, a youth-led network of local hubs.
PR
Pandu RaharjainCo-Founder2022–2024Pandu studied bioinformatics, computer science and mathematics at ETH Zurich, LMU Munich, the Technical University of Munich and the University of Cambridge. Over roughly eight years he has worked on machine learning, computational biology, mathematical modelling and cancer drug design, running research projects and products at organisations such as Siemens, Roche and Vodafone and publishing methods in biomedical image analysis and genomics.
Investors · 3
In the news
Frequently asked questions
- What does Panakeia do?
- Panakeia develops AI technology that derives multi-omics and biomarker information directly from routine H&E-stained tissue images, producing molecular profiling results in minutes rather than days or weeks. The company targets clinical diagnostics and drug development applications.
- Who founded Panakeia?
- Panakeia was founded by Pahini Pandya, Pandu Raharja in 2019.
- Who are Panakeia's investors?
- Panakeia's investors include Duke Capital Partners, Entrepreneur First, Hoxton Ventures.
- Where is Panakeia headquartered?
- Panakeia is headquartered in London, GB.